Proposed U.K. Budget Boost To Benefit Drug Industry
This article was originally published in The Pink Sheet Daily
Executive Summary
Amid drastic cuts in public-sector spending, the new U.K. government wants tax and regulatory changes to improve the environment for Big Pharma and biotech.
You may also be interested in...
UK Tax Perks Lure £500m GSK Investment
GSK responds to proposed U.K. tax changes by investing £500 million in manufacturing and setting up a U.K.-targeted venture capital fund
Advent's Life Science Fund Attracts UK Government Backing
Advent Venture Partners Raises £70 million for new life sciences fund in Europe.
Pipeline Watch: Phase III Readouts in Wilson Disease, Parkinson's Disease And COVID-19
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.